About Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie
"Das Spektrum unserer Klinik umfasst das gesamte Fachgebiet der Urologie, mit Ausnahme der Nierentransplantation. Dabei bestehen mit jährlich über 2.000 Operationen wesentliche Schwerpunkte im Bereich der chirurgischen Behandlung urologischer Tumore, der plastisch rekonstruktiven Chirurgie und der Behandlung der Inkontinenz. Außerdem sind wir seit 2008 ein von der Deutschen Krebshilfe zertifiziertes interdisziplinäres Prostatakarzinomzentrum."
Clinical Trials at Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie
During the past decade, Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie"
#1 collaborator was "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie
According to Clinical.Site data, the most researched conditions in "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie" are
"Carcinoma, Renal Cell" (1 trials), "Muscle-invasive Bladder Cancer" (1 trials), "Urinary Tract Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie
Most popular intervention types in "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Cabozantinib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie
The vast majority of trials in "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie" are
4 trials for "All" genders.
Clinical Trials Status at Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie
Currently, there are NaN active trials in "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".